MIRADOR Trademark

Trademark Overview


On Thursday, November 9, 2023, a trademark application was filed for MIRADOR with the United States Patent and Trademark Office. The USPTO has given the MIRADOR trademark a serial number of 98262771. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 1, 2024. This trademark is owned by Mirador Therapeutics, Inc.. The MIRADOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics
mirador

General Information


Serial Number98262771
Word MarkMIRADOR
Filing DateThursday, November 9, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Translation of Words in MarkThe English translation of "MIRADOR" in the mark is "vantage point".
Goods and ServicesResearch, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 11, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMirador Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirador Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, November 13, 2023NEW APPLICATION ENTERED
Monday, December 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 17, 2024ASSIGNED TO EXAMINER
Tuesday, June 18, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION